» Articles » PMID: 35756007

Gut Microbiota Characteristics Are Associated With Severity of Acute Radiation-Induced Esophagitis

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Jun 27
PMID 35756007
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute radiation-induced esophagitis (ARIE) is one of the most debilitating complications in patients who receive thoracic radiotherapy, especially those with esophageal cancer (EC). There is little known about the impact of the characteristics of gut microbiota on the initiation and severity of ARIE.

Materials And Methods: Gut microbiota samples of EC patients undergoing radiotherapy ( = 7) or concurrent chemoradiotherapy ( = 42) were collected at the start, middle, and end of the radiotherapy regimen. Assessment of patient-reported ARIE was also performed. Based on 16S rRNA gene sequencing, changes of the gut microbial community during the treatment regimen and correlations of the gut microbiota characteristics with the severity of ARIE were investigated.

Results: There were significant associations of several properties of the gut microbiota with the severity of ARIE. The relative abundance of several genera in the phylum Proteobacteria increased significantly as mucositis severity increased. The predominant genera had characteristic changes during the treatment regimen, such as an increase of opportunistic pathogenic bacteria including . Patients with severe ARIE had significantly lower alpha diversity and a higher abundance of before radiotherapy, but patients with mild ARIE were enriched in , , , , , and . A model combining these genera had the best performance in prediction of severe ARIE (area under the curve: 0.907).

Conclusion: The characteristics of gut microbiota before radiotherapy were associated with subsequent ARIE severity. Microbiota-based strategies have potential use for the early prediction of subsequent ARIE and for the selection of interventions that may prevent severe ARIE.

Citing Articles

Impact of Fusobacterium nucleatum in the treatment of cancer, including radiotherapy and its future potential in esophageal cancer.

Ohsawa M, Nishi H, Emi M, Yoshikawa T, Hamai Y, Ibuki Y J Radiat Res. 2024; 65(Supplement_1):i126-i134.

PMID: 39679879 PMC: 11647932. DOI: 10.1093/jrr/rrae061.


Efficacy and safety of QingReJieDu therapy in preventing acute radiation esophagitis: A systematic review and meta-analysis.

Wang J, Qiu D, Dong X, Liu Y, Chen J Medicine (Baltimore). 2024; 103(49):e40779.

PMID: 39654193 PMC: 11630928. DOI: 10.1097/MD.0000000000040779.


Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study.

Li X, Xu B, Yang H, Zhu Z Genes (Basel). 2024; 15(6).

PMID: 38927665 PMC: 11203100. DOI: 10.3390/genes15060729.


Salivary microbiome is associated with the response to chemoradiotherapy in initially inoperable patients with esophageal squamous cell carcinoma.

He Y, Li X, Hu A, Qian D J Oral Microbiol. 2024; 16(1):2359887.

PMID: 38813524 PMC: 11134033. DOI: 10.1080/20002297.2024.2359887.


Application of Mendelian randomization to assess host gene-gut microbiota correlations in patients with esophageal cancer.

Zhang Z, Zhang G, Huang Z, Shi Y, Wang D Front Microbiol. 2024; 14:1309596.

PMID: 38179450 PMC: 10764629. DOI: 10.3389/fmicb.2023.1309596.


References
1.
Liu J, Hsieh C, Gelincik O, Devolder B, Sei S, Zhang S . Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. J Proteomics. 2019; 195:125-137. DOI: 10.1016/j.jprot.2018.12.029. View

2.
Edgar R . UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013; 10(10):996-8. DOI: 10.1038/nmeth.2604. View

3.
Wang Q, Garrity G, Tiedje J, Cole J . Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73(16):5261-7. PMC: 1950982. DOI: 10.1128/AEM.00062-07. View

4.
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P . The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012; 41(Database issue):D590-6. PMC: 3531112. DOI: 10.1093/nar/gks1219. View

5.
Fujishima S, Aikawa N . Neutrophil-mediated tissue injury and its modulation. Intensive Care Med. 1995; 21(3):277-85. DOI: 10.1007/BF01701489. View